Page last updated: 2024-08-22

zalcitabine and Neutropenia

zalcitabine has been researched along with Neutropenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakshi, SS; Boone, G; Britto, P; Capparelli, E; Fowler, MG; Frank, Y; Jimenez, E; Mofenson, L; Pahwa, SG; Rasheed, S; Salgo, M; Schoenfeld, D; Yogev, R; Zimmer, B	1

Trials

1 trial(s) available for zalcitabine and Neutropenia

Article	Year
Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team. The Journal of infectious diseases, 1997, Volume: 175, Issue:5 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cause of Death; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Infant; Male; Neutropenia; Survival Rate; Time Factors; Zalcitabine; Zidovudine	1997

Article

Year

Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team.

The Journal of infectious diseases, 1997, Volume: 175, Issue:5

Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cause of Death; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Infant; Male; Neutropenia; Survival Rate; Time Factors; Zalcitabine; Zidovudine

1997